US5057426A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for separating long-chain nucleic acids
Assignee: DIAGEN INSTITUT fur MOLEKULAR-BIOLOGISCHE DIAGNOSTIK GmbH
•
Filing: 1987-11-23
•
Granted: 1991-10-15
•
Expires: 2007-11-23
Abstract
Abstract A method for the separation of long-chain nucleic acids from other substances in solutions containing nucleic acids and other materials, comprising fixing long-chain nucleic acids in a nucleic acid-containing solution onto a porous matrix, washing the porous matrix to separate the other substances from the long-chain nucleic acids, and removing the fixed long-chain nucleic acids from the porous matrix is disclosed. A device for carrying out the method of the claimed invention is also described.
Inventors
- 👤 Karsten Henco
- 👤 Arndt Stichel
- 👤 Metin Colpan
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-05 18:07
CPC Classifications
G; G01; G01N; G01N30/00; G01N30/02; G01N30/60; G01N30/6052; C; C12; C12N; C12N15/00; C12N15/09; C12N15/10; C12N15/1003; C12N15/1006; C12N15/101; G01N30/88; G01N2030/8809; G01N2030/8813; G01N2030/8827; G01N2030/8831; G01N2030/884; G01N2030/885; G01N30/6065; G01N30/6091
Claims Analysis
Total Claims: 22
Claim 1
Independent Claim
90 words
A method for the separation of long-chain nucleic acids from other substances in solutions containing nucleic acids and other materials, comprising: fixing long-chain nucleic acids in a nucleic acid-containing solution onto a porous matrix, said matrix being an anion exchanger, the porous matrix having a particle size of from about 15 to about 250 μm and a pore diameter of about 100 to 2500 nm; washing the porous matrix to separate the other substances from the long-chain nucleic acids; and removing the fixed long-chain nucleic acids from the porous matrix.
Claim 2
Independent Claim
90 words
A method for the separation of long-chain nucleic acids from other substances in solutions containing nucleic acids and other materials, comprising: fixing long-chain nucleic acids in a nucleic acid-containing solution onto a porous matrix, said matrix being an anion exchanger, the porous matrix having a particle size of from about 15 to about 250 μm and a pore diameter of about 100 to 2500 nm; washing the porous matrix to separate the other substances from the long-chain nucleic acids; and removing the fixed long-chain nucleic acids from the porous matrix.
Claim 3
Dependent Claim
36 words
The method of claim 1 wherein the nucleic acid-containing solution is a nucleic acid/protein mixture or biotechnical preparation of bacteria, viruses, animal or vegetable tissue or cells, a body liquid, cell ingredients or degradation products thereof.
Claim 4
Dependent Claim
40 words
The method according to claim 1, wherein the porous matrix is selected from the group consisting of silica gel, diatomite, aluminum oxide, titanium oxide, hydroxylapatite, dextran, agarose, acrylamide, polystyrene, polyvinyl alcohol or other organic polymers, and derivatives or copolymers thereof.
Claim 5
Dependent Claim
59 words
The method according to claim 1, wherein the porous matrix is a material for chromatography having been modified with respect to its surface, the material being based on a member selected from the group consisting of silica gel, diatomite, aluminum oxide, titanium oxide, hydroxylapatite, dextran, agarose, acrylamide, polystyrene, polyvinyl alcohol or other organic polymers, and derivatives or copolymers thereof.
Claim 6
Dependent Claim
26 words
The method according to claim 1, wherein the particle size is from about 25 to about 40 μm and the pore diameter is about 400 nm.
Claim 7
Dependent Claim
14 words
The method according to claim 1, wherein the nucleic acid-containing solution is essentially phenol-free.
Claim 8
Dependent Claim
14 words
The method according to claim 1, wherein the porous matrix has a hydrophilic surface.
Claim 9
Dependent Claim
41 words
The method according to claim 1, further comprising, before the step of fixing, the step of disintegrating cells from tissue or body liquid under mild conditions by means of enzymatic proteolysis, detergents, or mechanical procedures, to obtain the nucleic acid-containing solution.
Claim 10
Dependent Claim
19 words
The method according to claim 1, wherein the step of washing uses a washing solution of low ionic strength.
Claim 11
Dependent Claim
20 words
The method according to claim 1, wherein the step of removing is performed using a solution of high ionic strength.
Claim 12
Dependent Claim
23 words
The method according to claim 1, wherein the fixed long-chain nucleic acids are separated from protein in an amount of more than 99%.
Claim 13
Dependent Claim
23 words
The method according to claim 1, wherein the fixed long-chain nucleic acids are separated from protein in an amount of up to 100%.
Claim 14
Dependent Claim
21 words
The method according to claim 1, wherein the steps of fixing, washing and removing are carried out by a batch process.
Claim 15
Dependent Claim
22 words
The method according to claim 4, wherein the porous matrix modified with respect to its surface is modified with a silanating reagent.
Claim 16
Dependent Claim
26 words
The method according to claim 1, wherein the steps of fixing, washing and removing are carried out by gravity flow of fluids applied to the matrix.
Claim 17
Dependent Claim
30 words
The method of claim 1 wherein the nucleic acid is double stranded DNA, and said DNA is removed from the porous matrix with an elution buffer comprising 1.2 M NaCl.
Claim 18
Dependent Claim
30 words
The method of claim 1 wherein the nucleic acid is single stranded DNA, and said DNA is removed from the porous matrix with an elution buffer comprising 1.1 M NaCl.
Claim 19
Dependent Claim
23 words
The method of claim 1 wherein the nucleic acid is removed from the porous matrics with an elution buffer comprising 1.5 M NaCl.
Claim 20
Dependent Claim
29 words
The method of claim 1 wherein the nucleic acid is transfer RNA, and said RNA is removed from the porous matrix with an elution buffer comprising 0.5 M NaCl.
Claim 21
Dependent Claim
30 words
The method of claim 1 wherein the nucleic acid is 5S ribosomal RNA, and said RNA is removed from the porous matrix with an elution buffer comprising 0.65 M NaCl.
Claim 22
Dependent Claim
37 words
The method of claim 1 wherein the nucleic acid is 16S and 23S ribosomal RNA or messenger RNA, and said RNA is removed from the porous matrix with an elution buffer comprising 0.8 to 0.9 M NaCl.
References Cited (Backward Citations)
US3157635A
Cited
US3157636A
Cited
US3433782A
Cited
GB1331933A
Cited
US4430496A
Cited
EP0240191A2
Cited
US4935342A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-10-14 | 1995-04-15 | 1995-10-15 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-10-14 | 1999-04-15 | 1999-10-15 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-10-14 | 2003-04-15 | 2003-10-15 | $7700.00 | Window Closed / Lapsed |